Share Price and Basic Stock Data
Last Updated: November 26, 2025, 5:50 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Phyto Chem (India) Ltd, operating in the agrochemicals and pesticides sector, reported a market capitalization of ₹13.2 Cr and a share price of ₹30.7. In terms of revenue, the company experienced significant fluctuations in its sales figures over the past quarters. For instance, sales peaked at ₹12.47 Cr in September 2022 but plummeted to ₹0.64 Cr by June 2023, indicating a volatile performance. Annual sales have also shown a downward trend, with ₹26.76 Cr reported for March 2023, declining to ₹14.75 Cr in March 2024, and further to ₹14.08 Cr in March 2025. This decline in revenue reflects the challenges faced in the market, as the company has struggled to maintain consistent sales volumes amidst competitive pressures and operational inefficiencies.
Profitability and Efficiency Metrics
Phyto Chem’s profitability metrics reveal a concerning trend, with a reported net profit of ₹-0.01 Cr and an operating profit margin (OPM) of -34.67% as of the latest reporting period. The quarterly operating profits fluctuated, with a high of ₹2.50 Cr in September 2022, but turned negative in subsequent quarters, highlighting significant operational challenges. The company recorded a return on equity (ROE) of 14.6%, which, while positive, is overshadowed by a return on capital employed (ROCE) of only 3.27%. This disparity suggests that while shareholder returns are being generated, the capital efficiency remains low, indicating potential inefficiencies in asset utilization. Additionally, the cash conversion cycle (CCC) stood at a lengthy 615.87 days, reflecting inefficiencies in inventory management and accounts receivable processes.
Balance Sheet Strength and Financial Ratios
Phyto Chem’s balance sheet reveals a total borrowing of ₹15.77 Cr against reserves of ₹2.09 Cr, indicating a high leverage ratio. The debt-to-equity ratio stood at 2.47, which is significantly above typical industry levels, suggesting potential liquidity risks. The interest coverage ratio (ICR) was reported at 0.61x, which indicates that the company’s earnings are insufficient to cover its interest obligations, posing a risk to financial stability. The book value per share has declined from ₹24.68 in March 2023 to ₹14.85 in March 2025, reflecting a deterioration in net asset value. Furthermore, the current ratio was reported at 1.25, suggesting that while the company can meet its short-term liabilities, the financial cushion is relatively thin, emphasizing the need for improved operational cash flows.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Phyto Chem indicates a diverse ownership structure, with promoters holding 40.40% of the equity and the public holding 54.78%. Institutional ownership is minimal, with domestic institutional investors (DIIs) at 0.19% and no foreign institutional investors (FIIs) reported. This lack of institutional backing could be indicative of lower investor confidence, especially given the company’s recent financial performance. The number of shareholders has seen a slight increase to 7,303, which may reflect some level of interest in the stock despite its challenges. However, the consistent promoter holding suggests a commitment to the business, which could provide stability in times of market volatility.
Outlook, Risks, and Final Insight
Looking ahead, Phyto Chem faces several risks, including continued operational inefficiencies and high debt levels, which could impede growth and profitability. The company must address its lengthy cash conversion cycle and improve its operational efficiency to enhance profitability. However, the potential for recovery exists if management can implement effective strategies for market penetration and cost control. Additionally, external factors such as regulatory changes in the agrochemical sector and shifts in consumer preferences could influence future performance. While the company has the foundational elements to stabilize and grow, achieving this will require focused efforts on operational improvements and financial restructuring to attract more institutional investments and restore investor confidence.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Phyto Chem (India) Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Epigral Ltd | 6,336 Cr. | 1,468 | 2,196/1,398 | 15.8 | 487 | 0.41 % | 24.9 % | 22.3 % | 10.0 |
| Dharmaj Crop Guard Ltd | 834 Cr. | 246 | 391/165 | 17.1 | 131 | 0.00 % | 12.0 % | 9.28 % | 10.0 |
| Bhaskar Agrochemicals Ltd | 66.6 Cr. | 128 | 149/56.6 | 11.9 | 40.0 | 0.00 % | 21.3 % | 24.7 % | 10.0 |
| Bhagiradha Chemicals & Industries Ltd | 3,227 Cr. | 249 | 365/228 | 122 | 54.9 | 0.06 % | 7.44 % | 4.91 % | 1.00 |
| Best Agrolife Ltd | 858 Cr. | 362 | 670/244 | 67.0 | 342 | 0.83 % | 12.9 % | 9.95 % | 10.0 |
| Industry Average | 11,223.60 Cr | 1,496.94 | 32.99 | 472.46 | 0.43% | 15.21% | 19.87% | 7.25 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1.41 | 12.47 | 7.88 | 5.00 | 0.64 | 7.21 | 6.51 | 0.45 | 4.61 | 4.37 | 3.65 | 1.46 | 1.50 |
| Expenses | 2.23 | 9.97 | 7.60 | 4.36 | 1.91 | 6.67 | 5.76 | 3.74 | 5.63 | 3.81 | 3.48 | 2.51 | 2.02 |
| Operating Profit | -0.82 | 2.50 | 0.28 | 0.64 | -1.27 | 0.54 | 0.75 | -3.29 | -1.02 | 0.56 | 0.17 | -1.05 | -0.52 |
| OPM % | -58.16% | 20.05% | 3.55% | 12.80% | -198.44% | 7.49% | 11.52% | -731.11% | -22.13% | 12.81% | 4.66% | -71.92% | -34.67% |
| Other Income | 0.00 | 0.03 | 0.06 | 0.07 | 0.15 | 0.01 | 0.07 | 2.09 | 0.01 | 0.01 | 1.94 | 0.51 | 0.40 |
| Interest | 0.50 | 0.46 | 0.48 | 0.66 | 0.56 | 0.63 | 0.44 | 0.42 | 0.38 | 0.38 | 0.52 | 0.57 | 0.33 |
| Depreciation | 0.10 | 0.10 | 0.10 | 0.10 | 0.08 | 0.08 | 0.10 | 0.09 | 0.08 | 0.08 | 0.08 | 0.08 | 0.09 |
| Profit before tax | -1.42 | 1.97 | -0.24 | -0.05 | -1.76 | -0.16 | 0.28 | -1.71 | -1.47 | 0.11 | 1.51 | -1.19 | -0.54 |
| Tax % | 10.56% | 0.00% | 29.17% | -360.00% | 0.00% | 0.00% | 0.00% | 0.00% | -0.68% | 0.00% | -0.66% | -3.36% | -9.26% |
| Net Profit | -1.57 | 1.98 | -0.31 | 0.12 | -1.76 | -0.16 | 0.29 | -1.71 | -1.47 | 0.11 | 1.52 | -1.16 | -0.48 |
| EPS in Rs | -3.65 | 4.60 | -0.72 | 0.28 | -4.09 | -0.37 | 0.67 | -3.98 | -3.42 | 0.26 | 3.53 | -2.70 | -1.12 |
Last Updated: August 20, 2025, 5:20 am
Below is a detailed analysis of the quarterly data for Phyto Chem (India) Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 1.50 Cr.. The value appears strong and on an upward trend. It has increased from 1.46 Cr. (Mar 2025) to 1.50 Cr., marking an increase of 0.04 Cr..
- For Expenses, as of Jun 2025, the value is 2.02 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2.51 Cr. (Mar 2025) to 2.02 Cr., marking a decrease of 0.49 Cr..
- For Operating Profit, as of Jun 2025, the value is -0.52 Cr.. The value appears strong and on an upward trend. It has increased from -1.05 Cr. (Mar 2025) to -0.52 Cr., marking an increase of 0.53 Cr..
- For OPM %, as of Jun 2025, the value is -34.67%. The value appears strong and on an upward trend. It has increased from -71.92% (Mar 2025) to -34.67%, marking an increase of 37.25%.
- For Other Income, as of Jun 2025, the value is 0.40 Cr.. The value appears to be declining and may need further review. It has decreased from 0.51 Cr. (Mar 2025) to 0.40 Cr., marking a decrease of 0.11 Cr..
- For Interest, as of Jun 2025, the value is 0.33 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.57 Cr. (Mar 2025) to 0.33 Cr., marking a decrease of 0.24 Cr..
- For Depreciation, as of Jun 2025, the value is 0.09 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.08 Cr. (Mar 2025) to 0.09 Cr., marking an increase of 0.01 Cr..
- For Profit before tax, as of Jun 2025, the value is -0.54 Cr.. The value appears strong and on an upward trend. It has increased from -1.19 Cr. (Mar 2025) to -0.54 Cr., marking an increase of 0.65 Cr..
- For Tax %, as of Jun 2025, the value is -9.26%. The value appears to be improving (decreasing) as expected. It has decreased from -3.36% (Mar 2025) to -9.26%, marking a decrease of 5.90%.
- For Net Profit, as of Jun 2025, the value is -0.48 Cr.. The value appears strong and on an upward trend. It has increased from -1.16 Cr. (Mar 2025) to -0.48 Cr., marking an increase of 0.68 Cr..
- For EPS in Rs, as of Jun 2025, the value is -1.12. The value appears strong and on an upward trend. It has increased from -2.70 (Mar 2025) to -1.12, marking an increase of 1.58.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: August 23, 2025, 2:16 pm
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 29.29 | 40.92 | 21.77 | 44.45 | 58.90 | 59.11 | 44.22 | 44.49 | 23.12 | 26.76 | 14.75 | 14.08 | 10.98 |
| Expenses | 26.32 | 38.27 | 20.24 | 41.58 | 56.75 | 56.68 | 42.30 | 42.28 | 21.70 | 24.16 | 18.02 | 15.42 | 11.82 |
| Operating Profit | 2.97 | 2.65 | 1.53 | 2.87 | 2.15 | 2.43 | 1.92 | 2.21 | 1.42 | 2.60 | -3.27 | -1.34 | -0.84 |
| OPM % | 10.14% | 6.48% | 7.03% | 6.46% | 3.65% | 4.11% | 4.34% | 4.97% | 6.14% | 9.72% | -22.17% | -9.52% | -7.65% |
| Other Income | -0.06 | 0.12 | 0.68 | 0.27 | 1.55 | 0.98 | 1.38 | 0.80 | 1.29 | 0.16 | 2.32 | 2.47 | 2.86 |
| Interest | 1.63 | 1.64 | 1.72 | 1.67 | 2.13 | 2.10 | 2.47 | 2.12 | 2.10 | 2.10 | 2.05 | 1.84 | 1.80 |
| Depreciation | 0.35 | 0.32 | 0.31 | 0.31 | 0.36 | 0.40 | 0.41 | 0.43 | 0.41 | 0.40 | 0.34 | 0.34 | 0.33 |
| Profit before tax | 0.93 | 0.81 | 0.18 | 1.16 | 1.21 | 0.91 | 0.42 | 0.46 | 0.20 | 0.26 | -3.34 | -1.05 | -0.11 |
| Tax % | 34.41% | 34.57% | 38.89% | 26.72% | 23.97% | 19.78% | -4.76% | -6.52% | -15.00% | 15.38% | -0.30% | -5.71% | |
| Net Profit | 0.61 | 0.54 | 0.12 | 0.85 | 0.92 | 0.73 | 0.45 | 0.49 | 0.23 | 0.22 | -3.33 | -0.99 | -0.01 |
| EPS in Rs | 1.42 | 1.26 | 0.28 | 1.98 | 2.14 | 1.70 | 1.05 | 1.14 | 0.53 | 0.51 | -7.74 | -2.30 | -0.03 |
| Dividend Payout % | 70.49% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -11.48% | -77.78% | 608.33% | 8.24% | -20.65% | -38.36% | 8.89% | -53.06% | -4.35% | -1613.64% | 70.27% |
| Change in YoY Net Profit Growth (%) | 0.00% | -66.30% | 686.11% | -600.10% | -28.89% | -17.70% | 47.25% | -61.95% | 48.71% | -1609.29% | 1683.91% |
Phyto Chem (India) Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -10% |
| 5 Years: | -20% |
| 3 Years: | -15% |
| TTM: | -42% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 100% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -1% |
| 5 Years: | 4% |
| 3 Years: | 15% |
| 1 Year: | -5% |
| Return on Equity | |
|---|---|
| 10 Years: | -1% |
| 5 Years: | -8% |
| 3 Years: | -16% |
| Last Year: | -14% |
Last Updated: September 5, 2025, 12:30 pm
Balance Sheet
Last Updated: November 9, 2025, 2:43 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 |
| Reserves | 3.12 | 3.48 | 3.60 | 4.00 | 4.52 | 5.12 | 5.55 | 5.88 | 6.15 | 6.31 | 3.06 | 2.09 |
| Borrowings | 14.22 | 16.00 | 16.04 | 18.46 | 18.55 | 22.08 | 22.98 | 21.37 | 21.23 | 19.47 | 18.19 | 15.77 |
| Other Liabilities | 10.53 | 11.92 | 5.63 | 15.24 | 30.31 | 41.46 | 34.87 | 13.91 | 6.78 | 9.94 | 6.16 | 5.72 |
| Total Liabilities | 32.17 | 35.70 | 29.57 | 42.00 | 57.68 | 72.96 | 67.70 | 45.46 | 38.46 | 40.02 | 31.71 | 27.88 |
| Fixed Assets | 4.21 | 3.68 | 3.50 | 3.25 | 4.10 | 4.18 | 4.67 | 3.43 | 3.13 | 2.75 | 2.74 | 2.39 |
| CWIP | -0.00 | -0.00 | -0.00 | -0.00 | 0.09 | 0.45 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Investments | 0.32 | 0.32 | 0.32 | 0.24 | 0.25 | 0.12 | 0.11 | 0.16 | 0.17 | 0.07 | 0.08 | 0.05 |
| Other Assets | 27.64 | 31.70 | 25.75 | 38.51 | 53.24 | 68.21 | 62.92 | 41.87 | 35.16 | 37.20 | 28.89 | 25.44 |
| Total Assets | 32.17 | 35.70 | 29.57 | 42.00 | 57.68 | 72.96 | 67.70 | 45.46 | 38.46 | 40.02 | 31.71 | 27.88 |
Below is a detailed analysis of the balance sheet data for Phyto Chem (India) Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 4.30 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 4.30 Cr..
- For Reserves, as of Mar 2025, the value is 2.09 Cr.. The value appears to be declining and may need further review. It has decreased from 3.06 Cr. (Mar 2024) to 2.09 Cr., marking a decrease of 0.97 Cr..
- For Borrowings, as of Mar 2025, the value is 15.77 Cr.. The value appears to be improving (decreasing). However, Borrowings exceed Reserves, which may signal higher financial risk. It has decreased from 18.19 Cr. (Mar 2024) to 15.77 Cr., marking a decrease of 2.42 Cr..
- For Other Liabilities, as of Mar 2025, the value is 5.72 Cr.. The value appears to be improving (decreasing). It has decreased from 6.16 Cr. (Mar 2024) to 5.72 Cr., marking a decrease of 0.44 Cr..
- For Total Liabilities, as of Mar 2025, the value is 27.88 Cr.. The value appears to be improving (decreasing). It has decreased from 31.71 Cr. (Mar 2024) to 27.88 Cr., marking a decrease of 3.83 Cr..
- For Fixed Assets, as of Mar 2025, the value is 2.39 Cr.. The value appears to be declining and may need further review. It has decreased from 2.74 Cr. (Mar 2024) to 2.39 Cr., marking a decrease of 0.35 Cr..
- For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Investments, as of Mar 2025, the value is 0.05 Cr.. The value appears to be declining and may need further review. It has decreased from 0.08 Cr. (Mar 2024) to 0.05 Cr., marking a decrease of 0.03 Cr..
- For Other Assets, as of Mar 2025, the value is 25.44 Cr.. The value appears to be declining and may need further review. It has decreased from 28.89 Cr. (Mar 2024) to 25.44 Cr., marking a decrease of 3.45 Cr..
- For Total Assets, as of Mar 2025, the value is 27.88 Cr.. The value appears to be declining and may need further review. It has decreased from 31.71 Cr. (Mar 2024) to 27.88 Cr., marking a decrease of 3.83 Cr..
However, the Borrowings (15.77 Cr.) are higher than the Reserves (2.09 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -11.25 | -13.35 | -14.51 | -15.59 | -16.40 | -19.65 | -21.06 | -19.16 | -19.81 | -16.87 | -21.46 | -17.11 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 209.73 | 155.83 | 247.97 | 212.84 | 234.37 | 306.89 | 360.30 | 182.87 | 317.01 | 275.66 | 388.26 | 369.41 |
| Inventory Days | 167.93 | 159.73 | 260.64 | 133.35 | 115.59 | 128.58 | 182.77 | 172.49 | 342.41 | 314.83 | 373.42 | 338.21 |
| Days Payable | 99.24 | 113.43 | 86.08 | 135.72 | 176.25 | 283.01 | 338.07 | 110.32 | 41.10 | 122.87 | 91.09 | 91.75 |
| Cash Conversion Cycle | 278.42 | 202.12 | 422.53 | 210.47 | 173.71 | 152.46 | 205.00 | 245.04 | 618.32 | 467.62 | 670.59 | 615.87 |
| Working Capital Days | 59.32 | 48.26 | 103.95 | 53.62 | 43.75 | 45.14 | 69.58 | 85.08 | 155.35 | 150.45 | 161.34 | 129.88 |
| ROCE % | 13.06% | 12.02% | 7.75% | 11.16% | 12.34% | 10.16% | 8.98% | 6.96% | 7.28% | 7.55% | -4.93% | 3.27% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | -2.31 | -7.75 | 0.52 | 0.53 | 1.15 |
| Diluted EPS (Rs.) | -2.31 | -7.75 | 0.52 | 0.53 | 1.15 |
| Cash EPS (Rs.) | -1.52 | -6.95 | 1.44 | 1.49 | 2.14 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 14.85 | 17.11 | 24.68 | 24.31 | 23.68 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 14.85 | 17.11 | 24.68 | 24.31 | 23.68 |
| Revenue From Operations / Share (Rs.) | 32.74 | 34.44 | 62.23 | 53.76 | 103.46 |
| PBDIT / Share (Rs.) | 2.62 | -2.20 | 6.42 | 6.28 | 7.00 |
| PBIT / Share (Rs.) | 1.84 | -3.00 | 5.50 | 5.33 | 6.01 |
| PBT / Share (Rs.) | -2.44 | -7.76 | 0.61 | 0.45 | 1.08 |
| Net Profit / Share (Rs.) | -2.31 | -7.75 | 0.51 | 0.53 | 1.15 |
| PBDIT Margin (%) | 8.01 | -6.39 | 10.31 | 11.68 | 6.76 |
| PBIT Margin (%) | 5.62 | -8.70 | 8.83 | 9.91 | 5.80 |
| PBT Margin (%) | -7.44 | -22.54 | 0.98 | 0.85 | 1.04 |
| Net Profit Margin (%) | -7.04 | -22.48 | 0.83 | 0.99 | 1.10 |
| Return on Networth / Equity (%) | -15.52 | -45.25 | 2.09 | 2.19 | 4.84 |
| Return on Capital Employeed (%) | 9.82 | -12.59 | 16.06 | 16.83 | 17.57 |
| Return On Assets (%) | -3.55 | -10.50 | 0.55 | 0.60 | 1.09 |
| Long Term Debt / Equity (X) | 0.13 | 0.23 | 0.26 | 0.22 | 0.35 |
| Total Debt / Equity (X) | 2.47 | 2.47 | 1.83 | 1.88 | 1.89 |
| Asset Turnover Ratio (%) | 0.47 | 0.41 | 0.68 | 0.55 | 0.78 |
| Current Ratio (X) | 1.25 | 1.31 | 1.44 | 1.40 | 1.35 |
| Quick Ratio (X) | 0.73 | 0.75 | 0.85 | 0.88 | 0.81 |
| Inventory Turnover Ratio (X) | 0.95 | 0.75 | 1.31 | 0.94 | 2.24 |
| Interest Coverage Ratio (X) | 0.61 | -0.46 | 1.31 | 1.29 | 1.42 |
| Interest Coverage Ratio (Post Tax) (X) | 0.46 | -0.62 | 1.11 | 1.11 | 1.23 |
| Enterprise Value (Cr.) | 28.18 | 31.77 | 33.51 | 28.18 | 26.50 |
| EV / Net Operating Revenue (X) | 2.00 | 2.15 | 1.25 | 1.22 | 0.59 |
| EV / EBITDA (X) | 24.97 | -33.54 | 12.14 | 10.43 | 8.81 |
| MarketCap / Net Operating Revenue (X) | 0.88 | 0.92 | 0.52 | 0.37 | 0.16 |
| Price / BV (X) | 1.95 | 1.87 | 1.33 | 0.83 | 0.72 |
| Price / Net Operating Revenue (X) | 0.88 | 0.92 | 0.52 | 0.37 | 0.16 |
| EarningsYield | -0.07 | -0.24 | 0.01 | 0.02 | 0.06 |
After reviewing the key financial ratios for Phyto Chem (India) Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -2.31. This value is below the healthy minimum of 5. It has increased from -7.75 (Mar 24) to -2.31, marking an increase of 5.44.
- For Diluted EPS (Rs.), as of Mar 25, the value is -2.31. This value is below the healthy minimum of 5. It has increased from -7.75 (Mar 24) to -2.31, marking an increase of 5.44.
- For Cash EPS (Rs.), as of Mar 25, the value is -1.52. This value is below the healthy minimum of 3. It has increased from -6.95 (Mar 24) to -1.52, marking an increase of 5.43.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 14.85. It has decreased from 17.11 (Mar 24) to 14.85, marking a decrease of 2.26.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 14.85. It has decreased from 17.11 (Mar 24) to 14.85, marking a decrease of 2.26.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 32.74. It has decreased from 34.44 (Mar 24) to 32.74, marking a decrease of 1.70.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 2.62. This value is within the healthy range. It has increased from -2.20 (Mar 24) to 2.62, marking an increase of 4.82.
- For PBIT / Share (Rs.), as of Mar 25, the value is 1.84. This value is within the healthy range. It has increased from -3.00 (Mar 24) to 1.84, marking an increase of 4.84.
- For PBT / Share (Rs.), as of Mar 25, the value is -2.44. This value is below the healthy minimum of 0. It has increased from -7.76 (Mar 24) to -2.44, marking an increase of 5.32.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -2.31. This value is below the healthy minimum of 2. It has increased from -7.75 (Mar 24) to -2.31, marking an increase of 5.44.
- For PBDIT Margin (%), as of Mar 25, the value is 8.01. This value is below the healthy minimum of 10. It has increased from -6.39 (Mar 24) to 8.01, marking an increase of 14.40.
- For PBIT Margin (%), as of Mar 25, the value is 5.62. This value is below the healthy minimum of 10. It has increased from -8.70 (Mar 24) to 5.62, marking an increase of 14.32.
- For PBT Margin (%), as of Mar 25, the value is -7.44. This value is below the healthy minimum of 10. It has increased from -22.54 (Mar 24) to -7.44, marking an increase of 15.10.
- For Net Profit Margin (%), as of Mar 25, the value is -7.04. This value is below the healthy minimum of 5. It has increased from -22.48 (Mar 24) to -7.04, marking an increase of 15.44.
- For Return on Networth / Equity (%), as of Mar 25, the value is -15.52. This value is below the healthy minimum of 15. It has increased from -45.25 (Mar 24) to -15.52, marking an increase of 29.73.
- For Return on Capital Employeed (%), as of Mar 25, the value is 9.82. This value is below the healthy minimum of 10. It has increased from -12.59 (Mar 24) to 9.82, marking an increase of 22.41.
- For Return On Assets (%), as of Mar 25, the value is -3.55. This value is below the healthy minimum of 5. It has increased from -10.50 (Mar 24) to -3.55, marking an increase of 6.95.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.13. This value is below the healthy minimum of 0.2. It has decreased from 0.23 (Mar 24) to 0.13, marking a decrease of 0.10.
- For Total Debt / Equity (X), as of Mar 25, the value is 2.47. This value exceeds the healthy maximum of 1. There is no change compared to the previous period (Mar 24) which recorded 2.47.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.47. It has increased from 0.41 (Mar 24) to 0.47, marking an increase of 0.06.
- For Current Ratio (X), as of Mar 25, the value is 1.25. This value is below the healthy minimum of 1.5. It has decreased from 1.31 (Mar 24) to 1.25, marking a decrease of 0.06.
- For Quick Ratio (X), as of Mar 25, the value is 0.73. This value is below the healthy minimum of 1. It has decreased from 0.75 (Mar 24) to 0.73, marking a decrease of 0.02.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.95. This value is below the healthy minimum of 4. It has increased from 0.75 (Mar 24) to 0.95, marking an increase of 0.20.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 0.61. This value is below the healthy minimum of 3. It has increased from -0.46 (Mar 24) to 0.61, marking an increase of 1.07.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 0.46. This value is below the healthy minimum of 3. It has increased from -0.62 (Mar 24) to 0.46, marking an increase of 1.08.
- For Enterprise Value (Cr.), as of Mar 25, the value is 28.18. It has decreased from 31.77 (Mar 24) to 28.18, marking a decrease of 3.59.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.00. This value is within the healthy range. It has decreased from 2.15 (Mar 24) to 2.00, marking a decrease of 0.15.
- For EV / EBITDA (X), as of Mar 25, the value is 24.97. This value exceeds the healthy maximum of 15. It has increased from -33.54 (Mar 24) to 24.97, marking an increase of 58.51.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.88. This value is below the healthy minimum of 1. It has decreased from 0.92 (Mar 24) to 0.88, marking a decrease of 0.04.
- For Price / BV (X), as of Mar 25, the value is 1.95. This value is within the healthy range. It has increased from 1.87 (Mar 24) to 1.95, marking an increase of 0.08.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.88. This value is below the healthy minimum of 1. It has decreased from 0.92 (Mar 24) to 0.88, marking a decrease of 0.04.
- For EarningsYield, as of Mar 25, the value is -0.07. This value is below the healthy minimum of 5. It has increased from -0.24 (Mar 24) to -0.07, marking an increase of 0.17.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Phyto Chem (India) Ltd:
- Net Profit Margin: -7.04%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 9.82% (Industry Average ROCE: 15.21%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -15.52% (Industry Average ROE: 19.87%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0.46
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.73
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 32.99)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 2.47
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -7.04%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Agro Chemicals/Pesticides | Survey No.628, Temple Street, Sangareddy Dist. Telangana 502313 | investorsrelations@phytochemindia.com www.phytochemindia.com |
| Management | |
|---|---|
| Name | Position Held |
| Dr. P Sreemannarayana | Chairman |
| Mr. Y Nayudamma | Managing Director |
| Mr. Y Janaki Ramaiah | Executive Director |
| Mr. S Y Sampath Kumar | Independent Director |
| Dr. M Sreerama Murthy | Independent Director |
| Mrs. G Vijitha | Independent Director |
| Mr. N Nagendra Naidu | Independent Director |
| Mr. N Sudhaka | Addnl.Non Exe.Independent Director |
| Mr. Y Sreemannarayana | Addnl.Non Exe.Independent Director |
| Mr. K Srinivasa Rao | Additional Non Exe.Non Ind.Director |
FAQ
What is the intrinsic value of Phyto Chem (India) Ltd?
Phyto Chem (India) Ltd's intrinsic value (as of 27 November 2025) is 22.34 which is 25.53% lower the current market price of 30.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 12.9 Cr. market cap, FY2025-2026 high/low of 39.9/24.5, reserves of ₹2.09 Cr, and liabilities of 27.88 Cr.
What is the Market Cap of Phyto Chem (India) Ltd?
The Market Cap of Phyto Chem (India) Ltd is 12.9 Cr..
What is the current Stock Price of Phyto Chem (India) Ltd as on 27 November 2025?
The current stock price of Phyto Chem (India) Ltd as on 27 November 2025 is 30.0.
What is the High / Low of Phyto Chem (India) Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Phyto Chem (India) Ltd stocks is 39.9/24.5.
What is the Stock P/E of Phyto Chem (India) Ltd?
The Stock P/E of Phyto Chem (India) Ltd is .
What is the Book Value of Phyto Chem (India) Ltd?
The Book Value of Phyto Chem (India) Ltd is 12.5.
What is the Dividend Yield of Phyto Chem (India) Ltd?
The Dividend Yield of Phyto Chem (India) Ltd is 0.00 %.
What is the ROCE of Phyto Chem (India) Ltd?
The ROCE of Phyto Chem (India) Ltd is 3.27 %.
What is the ROE of Phyto Chem (India) Ltd?
The ROE of Phyto Chem (India) Ltd is 14.6 %.
What is the Face Value of Phyto Chem (India) Ltd?
The Face Value of Phyto Chem (India) Ltd is 10.0.